HP Poaches Medtronic Finance Chief Karen Parkhill
By Colin Kellaher
HP has hired Karen Parkhill as its next chief financial officer, plucking the executive from medical-technology company Medtronic.
HP on Wednesday said Parkhill, who has been Medtronic's finance chief since 2016, will join the Palo Alto, Calif., maker of PCs and printers on Aug. 5.
Medtronic said Parkhill, 58 years old, will remain in her post until Aug. 2, adding that Gary Corona, currently senior vice president of global financial planning and analysis, will step in as interim chief financial officer upon her departure.
The Dublin-based company said it is looking at internal and external candidates for a successor to Parkhill.
HP said Parkhill will receive an annual base salary of $950,000 and an annual cash bonus with a target of 135% of her base pay.
The company said Tim Brown, who has been serving as interim finance chief since Marie Myers left to take the same post at corporate cousin Hewlett-Packard Enterprise, will return to his role as the head of print finance.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
June 26, 2024 09:34 ET (13:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Q3 2024 Stock Market Outlook: Is the AI Stock Trade Over?
-
Ian Bremmer: 4 Big Geopolitical Risks to Watch
-
What’s Happening In the Markets This Week
-
Obesity Drug Stocks: Why It Will Be ‘Exceptionally Difficult’ to Dethrone Eli Lilly and Novo Nordisk
-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
What a Strong Economy Now Means for the Rest of 2024
-
10 Top Dividend Stocks for 2024
-
Finding Small-Cap Stock Opportunities In a Big-Cap World
-
The 10 Best Companies to Invest in Now
-
Nike Earnings: Dim Sales Outlook Slams Shares, but Patient Investors Could Be Rewarded
-
2 Top E-Commerce Stock Picks
-
Our Top Pick for Investing in US Renewable Energy
-
Micron Earnings: We Raise Our DRAM Forecast and Valuation Behind Stronger Pricing Assumptions
-
10 Undervalued Wide-Moat Stocks